A Case of Pure Red Cell Aplasia Complicated with Diffuse Large B Cell Lymphoma, T-Cell-Rich/Histiocyte-Rich Variant: Effectiveness of Rituximab and Implications for a Common Immunopathogenic Role of B Lymphocytes

Publisher： Karger

E-ISSN： 1421-9662|113|3|194-197

ISSN： 0001-5792

Source： Acta Haematologica, Vol.113, Iss.3, 2005-05, pp. : 194-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matched-Pair Analysis Comparing the Outcomes of T Cell/Histiocyte-Rich Large B Cell Lymphoma and Diffuse Large B Cell Lymphoma in Patients Treated with Rituximab-CHOP

By  

Acta Haematologica, Vol. 131, Iss. 3, 2013-10 ,pp. : 156-161

Karger

Access to resources Recommend Favorite

Rituximab plus Ifosfamide, Carboplatin and Etoposide for T-Cell/Histiocyte-Rich B-Cell Lymphoma Arising in Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-08 ,pp. : 413-419

Karger

Access to resources Recommend Favorite

Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 3, 2015-05 ,pp. : 415-422

John Wiley & Sons Inc

Access to resources Recommend Favorite

T-Cell-Rich B-Cell Lymphoma

By  

Oncology, Vol. 61, Iss. 4, 2001-11 ,pp. : 257-264

Karger

Access to resources Recommend Favorite

Excellent outcomes and lack of prognostic impact of cell of origin for localized diffuse large B‐cell lymphoma in the rituximab era

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 5, 2015-12 ,pp. : 776-783

John Wiley & Sons Inc

Access to resources Recommend Favorite